Reply to Kovesi, to Chabra, and to Farber: "Palivizumab Prophylaxis and Recurrent Wheezing" and "Precise Gestational Age Definitions Needed for Palivizumab Prophylaxis in Preterm Infants" and "Imbalance in Level of Tobacco Smoke Exposure Between Groups Likely Explains the "Effect" of Palivizumab on Subsequent Wheezing"

Eric A F Simões^{1

2}, Hiroyuki Mochizuki³; all authors

Affiliations

Comment

Eric A F Simões et al. Am J Respir Crit Care Med. 2018.

. 2018 Mar 1;197(5):681-682.

doi: 10.1164/rccm.201709-1894LE.

Eric A F Simões^{1

2}, Hiroyuki Mochizuki³; all authors

No abstract available

Comment on

Palivizumab Prophylaxis in Preterm Infants and Subsequent Recurrent Wheezing. Six-Year Follow-up Study.
Mochizuki H, Kusuda S, Okada K, Yoshihara S, Furuya H, Simões EAF; Scientific Committee for Elucidation of Infantile Asthma. Mochizuki H, et al. Am J Respir Crit Care Med. 2017 Jul 1;196(1):29-38. doi: 10.1164/rccm.201609-1812OC. Am J Respir Crit Care Med. 2017. PMID: 28152315
Palivizumab Prophylaxis and Recurrent Wheezing.
Kovesi T. Kovesi T. Am J Respir Crit Care Med. 2018 Mar 1;197(5):679-680. doi: 10.1164/rccm.201708-1643LE. Am J Respir Crit Care Med. 2018. PMID: 29019698 No abstract available.
Precise Gestational Age Definitions Needed for Palivizumab Prophylaxis in Preterm Infants.
Chabra S. Chabra S. Am J Respir Crit Care Med. 2018 Mar 1;197(5):680. doi: 10.1164/rccm.201708-1605LE. Am J Respir Crit Care Med. 2018. PMID: 29019701 No abstract available.
Imbalance in Level of Tobacco Smoke Exposure Between Groups Likely Explains the "Effect" of Palivizumab on Subsequent Wheezing.
Farber HJ. Farber HJ. Am J Respir Crit Care Med. 2018 Mar 1;197(5):680-681. doi: 10.1164/rccm.201707-1527LE. Am J Respir Crit Care Med. 2018. PMID: 29019703 No abstract available.